Antiviral agents: clinical status report.

Abstract

Recently, the clinical focus in antiviral chemotherapy has been on the use of ara-A in herpes infections-HSV encephalitis, zoster in the immunosuppressed, and neonatal herpes. In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates.

• Authors: R J Whitley, C A Alford
• Journal: Hospital practice (Office ed.) (Hosp Pract (Off Ed)) Vol. 16 Issue 7 Pg. 109-21 (Jul 1981) ISSN: 8750-2836 [Print] United States
• PMID: 6788666 (Publication Type: Journal Article)

Chemical References

• Vidarabine

Topics

• Encephalitis (diagnosis, drug therapy)
• Herpes Simplex (diagnosis, drug therapy)
• Herpes Zoster (diagnosis, drug therapy)
• Humans
• Immunosuppression Therapy
• Infant, Newborn
• Infant, Newborn, Diseases (diagnosis, drug therapy)
• Prognosis
• Vidarabine (therapeutic use)